Concentra Group Holdings Parent, Inc. (CON)
| Market Cap | 5.10B +90.3% |
| Revenue (ttm) | 2.29B +14.0% |
| Net Income | 195.03M +33.1% |
| EPS | 1.53 +29.4% |
| Shares Out | 127.52M |
| PE Ratio | 26.19 |
| Forward PE | 23.19 |
| Dividend | $0.25 (0.63%) |
| Ex-Dividend Date | Aug 20, 2026 |
| Volume | 1,035,578 |
| Open | 40.21 |
| Previous Close | 40.20 |
| Day's Range | 39.74 - 40.43 |
| 52-Week Range | 18.55 - 40.43 |
| Beta | 0.63 |
| Analysts | Strong Buy |
| Price Target | 42.00 (+5.0%) |
| Earnings Date | Nov 5, 2026 |
About CON
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business. It offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services. It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries a... [Read more]
Financial Performance
In 2025, CON's revenue was $2.16 billion, an increase of 13.85% compared to the previous year's $1.90 billion. Earnings were $164.17 million, a decrease of -1.30%.
Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for CON stock is "Strong Buy." The 12-month stock price target is $42.0, which is an increase of 5.00% from the latest price.
News
Concentra initiated with an Overweight at Stephens
Stephens initiated coverage of Concentra (CON) with an Overweight rating and $45 price target Concentra has a differentiated occupational health center model, scale, a “competitive earnings algorithm”...
Concentra Expands Occupational Health Access in Greater Washington D.C. Metro with New Arlington Medical Center
ARLINGTON, Va.--(BUSINESS WIRE)--Concentra®, the nation's largest provider of occupational health services, is expanding its Washington, D.C.-area network with a new medical center in Arlington, Virgi...
Concentra initiated with a Buy at Jefferies
Jefferies initiated coverage of Concentra (CON) with a Buy rating and $47 price target The firm views Concentra as a “high-quality compounder” with a “differentiated” return on invested capital. Conce...
Concentra to Announce Third Quarter 2026 Results on Thursday, November 5, 2026
DALLAS--(BUSINESS WIRE)--Concentra® Group Holdings Parent, Inc. (“Concentra”) (NYSE: CON) will release the financial results for its third quarter ended September 30, 2026, on Thursday, November 5, 20...
Concentra announces Daytona Beach medical center
Concentra (CON) announced the opening of its newest Florida medical center and first location in Volusia County. The Daytona Beach medical center expands access to occupational health services for emp...
Concentra Expands Florida Footprint with New Daytona Beach Medical Center
DAYTONA BEACH, Fla.--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation's leader in occupational medicine and workforce health services, today announced the opening of its newest Florida medical cent...
Concentra price target raised to $43 from $34 at JPMorgan
JPMorgan raised the firm’s price target on Concentra (CON) to $43 from $34 and keeps an Overweight rating on the shares. The firm updated the company’s model. Published first on…
Concentra Group Holdings Parent Transcript: Wells Fargo 21st Annual Healthcare Conference
Leadership transitions are proceeding smoothly with experienced internal candidates. Strong visit growth, especially in workers' comp and onsite services, has led to raised guidance and margin expansion. Technology upgrades and operational efficiencies are supporting continued growth and improved employer value.
Concentra appoints Newton as EVP, CFO
Concentra (CON) announced that Tanner Newton, senior vice president of strategy and finance, has been appointed executive vice president, EVP, and chief financial officer, CFO, effective Nov. 1, 2026....
Concentra Appoints Tanner Newton Chief Financial Officer
DALLAS--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation's leader in occupational medicine and workforce health services, today announced that Tanner Newton, senior vice president of strategy and f...
Concentra appoints Rosenthal as Chief Medical Officer
Concentra (CON) announced that Jill Rosenthal, MD, MPH, will join the company Sept. 1 and assume the role of chief medical officer, effective Jan. 1, 2027. Returning to the organization…
Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health
DALLAS--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation's leader in occupational medicine, today announced that nationally recognized occupational medicine leader Jill Rosenthal, MD, MPH, will joi...
Concentra completes acquisition of four MOH medical centers in Twin Cities
Concentra (CON) announced completion of its acquisition of four Minnesota Occupational Health, MOH, medical centers in the Twin Cities. The acquisition strengthens access to specialized occupational h...
Concentra Strengthens Workforce Health Access in Minnesota Through Acquisition
DALLAS & MINNEAPOLIS & ST. PAUL, Minn.--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation's leader in occupational and workforce health services, today announced completion of its acquisition of fou...
Concentra price target raised to $40 from $36 at BofA
BofA analyst Joanna Gajuk raised the firm’s price target on Concentra (CON) to $40 from $36 and keeps a Buy rating on the shares after having hosted management at the…
Concentra price target raised to $40 from $34 at Goldman Sachs
Goldman Sachs analyst Scott Fidel raised the firm’s price target on Concentra (CON) to $40 from $34 and keeps a Buy rating on the shares. Concentra is executing well on…
Concentra price target raised to $40 from $28 at Wells Fargo
Wells Fargo raised the firm’s price target on Concentra (CON) to $40 from $28 and keeps an Overweight rating on the shares. The firm is also increasing its EBITDA estimates…
Concentra price target raised to $42 from $37 at Truist
Truist analyst David MacDonald raised the firm’s price target on Concentra (CON) to $42 from $37 and keeps a Buy rating on the shares. The firm remains bullish on Concentra…
Concentra to Present at Upcoming Investor Conferences
DALLAS--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. (NYSE: CON), the nation's largest provider of occupational health services by number of locations, today announced that executive and sen...
Concentra price target raised to $41 from $32 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Concentra (CON) to $41 from $32 and keeps a Buy rating on the shares.
Concentra price target raised to $40 from $35 at Mizuho
Mizuho analyst Ann Hynes raised the firm’s price target on Concentra (CON) to $40 from $35 and keeps an Outperform rating on the shares.
Concentra Group Holdings Parent Earnings Call Transcript: Q2 2026
Q2 2026 saw double-digit revenue growth, margin expansion, and strong free cash flow, prompting raised full-year guidance for revenue, EBITDA, and free cash flow. Leadership transition to a new CEO is underway, and operational execution remains strong amid favorable market trends.
Concentra Group Holdings Parent Earnings release: Q2 2026
Concentra Group Holdings Parent released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
Concentra Group Holdings Parent Quarterly report: Q2 2026
Concentra Group Holdings Parent has published its Q2 2026 quarterly earnings report on August 7, 2026.
Concentra Group Holdings Parent Slides: Q2 2026
Concentra Group Holdings Parent has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 7, 2026.